Bearbmagovva

Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women.

Objective: To evaluate the efficacy and side effects of Oxybutinin in comparison to tolterodine in treatment of overactive bladder (OAB) with detrussor overactivity (DOA) in Iranian women. Materials and methods: One hundred Iranian old women with clinical symptoms of OAB who show IDO in the filling...

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkkit:	Elham Aziminekoo (Dahkki), Zinat Ghanbari (Dahkki), Shahrzad Hashemi (Dahkki), Maryam Nemati (Dahkki), Fedyeh Haghollahi (Dahkki), Nasim Shokuhi (Dahkki)
Materiálatiipa:	Girji
Almmustuhtton:	Tehran University of Medical Sciences, 2014-06-01T00:00:00Z.
Fáttát:	article
Liŋkkat:	Connect to this object online.
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid

Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context
Dahkki: Rodrigo Silva Suguino, et al.
Almmustuhtton: (2012)

Clinical and urodynamic effects of tolterodine in women with an overactive bladder
Dahkki: Chiu-Lin Wang, et al.
Almmustuhtton: (2013)

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
Dahkki: Rajan Rajabalaya, et al.
Almmustuhtton: (2016)

Treatment efficacy of tolterodine versus belladonna mixture in children with idiopathic overactive bladder
Dahkki: Zheming Xu, et al.
Almmustuhtton: (2019)

Effect of Urinary Incontinence on Quality of Life among Iranian Women.
Dahkki: Fatemeh Mallah, et al.
Almmustuhtton: (2014)

Oxybutynin extended release for the management of overactive bladder: a clinical review
Dahkki: AM Arisco, et al.
Almmustuhtton: (2009)

OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN
Dahkki: L.B. Menovshchikova, et al.
Almmustuhtton: (2009)

OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN
Dahkki: L.B. Menovshchikova, et al.
Almmustuhtton: (2009)

Overactive bladder
Dahkki: Anna Zwierzyńska
Almmustuhtton: (2021)

Effects of 4-Ethylamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate Hydrochloride, a Metabolite of Oxybutynin, on Bladder Specimens and Rhythmic Bladder Contraction in Rats in Comparison With Oxybutynin
Dahkki: Masayuki Uchida, et al.
Almmustuhtton: (2004)

The Experimental overactive bladder modelling
Dahkki: O. I. Iatsyna, et al.
Almmustuhtton: (2018)

The Experimental overactive bladder modelling
Dahkki: O. I. Iatsyna, et al.
Almmustuhtton: (2018)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
Dahkki: E.L. Vishnevskiy
Almmustuhtton: (2007)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
Dahkki: E.L. Vishnevskiy
Almmustuhtton: (2007)

Intravesical Oxybutynin for Urgent Bladder Rescue in a Newborn with Posterior Urethral Valves
Dahkki: Ada Molina Caballero, et al.
Almmustuhtton: (2019)

Overactive bladder: An underestimated troublesome problem in women
Dahkki: Yiu-Tai Li, et al.
Almmustuhtton: (2022)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
Dahkki: Stacey Tannenbaum, et al.
Almmustuhtton: (2020)

Chapter Biomarkers in the Overactive Bladder Syndrome
Dahkki: Silva, Carlos
Almmustuhtton: (2012)

Chapter Biomarkers in the Overactive Bladder Syndrome
Dahkki: Silva, Carlos
Almmustuhtton: (2012)

New in the diagnosis of overactive bladder (review)
Dahkki: F N Mahmedzhanova, et al.
Almmustuhtton: (2013)

Mirabegron in the Management of Overactive Bladder Syndrome
Dahkki: O'Kane M, et al.
Almmustuhtton: (2022)

The Frequency of Pelvic Floor Dysfunctions and their Risk Factors in Women aged 40-55
Dahkki: Tahereh Eftekhar, et al.
Almmustuhtton: (2012)

Overactive bladder (OAB) in women: questionnaire based approach
Dahkki: Veena Ganju Malla, et al.
Almmustuhtton: (2020)

Muscarinic receptor binding of fesoterodine, 5-hydroxymethyl tolterodine, and tolterodine in rat tissues after the oral, intravenous, or intravesical administration
Dahkki: Shizuo Yamada, et al.
Almmustuhtton: (2019)

The application of botulinum toxin in the treatment of overactive bladder
Dahkki: Justyna Wojcik, et al.
Almmustuhtton: (2020)

The overactive bladder model anatomical and morphological correlates
Dahkki: O. I. Iatsyna
Almmustuhtton: (2018)

The overactive bladder model anatomical and morphological correlates
Dahkki: O. I. Iatsyna
Almmustuhtton: (2018)

Fesoterodine for the treatment of urinary incontinence and overactive bladder
Dahkki: Pamela Ellsworth
Almmustuhtton: (2009)

The Association of Bladder Wall Thickness with Severity of Symptoms in Patients with Overactive Bladder
Dahkki: Ronny Adrian, et al.
Almmustuhtton: (2017)

Comparison of Pelvic Floor Muscle Function in Women With Stress Urinary Incontinence and Overactive Bladder and Healthy Women
Dahkki: Delara Kasaeian, et al.
Almmustuhtton: (2022)

Evaluation of quality of life in women with overactive bladder (a survey)
Dahkki: F N Makhmejanova
Almmustuhtton: (2014)

Relationship between anxiety and overactive bladder syndrome in older women
Dahkki: Aline Teixeira Alves, et al.
Almmustuhtton: (2014)

Childhood nocturnal enuresis and clinical course of overactive bladder in women
Dahkki: Igor V. Kuzmin, et al.
Almmustuhtton: (2024)

Learning Curve of Botulinum Toxin Bladder Injection for the Treatment of Refractory Overactive Bladder
Dahkki: Barba M, et al.
Almmustuhtton: (2022)

Oxybutynin as an alternative treatment for hyperhidrosis
Dahkki: Sergio Delort, et al.
Almmustuhtton: (2017)

Literature Review: Quality of Life in Patients with Overactive Bladder
Dahkki: Vitaria Wahyu Astuti, et al.
Almmustuhtton: (2022)

Clinical Correlation Between Overactive Bladder and Allergy in Children
Dahkki: Lu Yin, et al.
Almmustuhtton: (2022)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
Dahkki: Frankel J, et al.
Almmustuhtton: (2022)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
Dahkki: Sharaf A, et al.
Almmustuhtton: (2017)

Medicinal plants and natural products for treating overactive bladder
Dahkki: Huanxian Chen, et al.
Almmustuhtton: (2024)